These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6733179)

  • 41. Neuropsychological assessment in behavioral toxicology--developing techniques and interpretative issues.
    Lezak MD
    Scand J Work Environ Health; 1984; 10 Suppl 1():25-9. PubMed ID: 6494852
    [No Abstract]   [Full Text] [Related]  

  • 42. The effects of a benzodiazepine receptor antagonist beta-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills.
    Duka T; Ott H; Rohloff A; Voet B
    Psychopharmacology (Berl); 1996 Feb; 123(4):361-73. PubMed ID: 8867876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance.
    Gordon CR; Gonen A; Nachum Z; Doweck I; Spitzer O; Shupak A
    J Psychopharmacol; 2001 Sep; 15(3):167-72. PubMed ID: 11565623
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impairment of cognition, risk-taking, and self-perception by alcohol.
    Mongrain S; Standing L
    Percept Mot Skills; 1989 Aug; 69(1):199-210. PubMed ID: 2780180
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of transdermal scopolamine on simulated ship navigation and attention/reaction time.
    Howland J; Rohsenow DJ; Minsky S; Snoberg J; Tagerud S; Hunt SK; Almeida A; Greece J; Allensworth-Davies D
    Int J Occup Environ Health; 2008; 14(4):250-6. PubMed ID: 19043911
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Arousal, temporal and spatial uncertainty and drug effects.
    Hartley LR
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(1):29-37. PubMed ID: 6134305
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Performance and drugs. Activation, coordination, concentration and control as pharmacologic effects].
    Debus G
    Arch Psychol (Frankf); 1988; 140(4):247-59. PubMed ID: 3075446
    [No Abstract]   [Full Text] [Related]  

  • 48. Human d-amphetamine drug discrimination: testing with d-amphetamine and hydromorphone.
    Lamb RJ; Henningfield JE
    NIDA Res Monogr; 1989; 95():423-4. PubMed ID: 2484268
    [No Abstract]   [Full Text] [Related]  

  • 49. The specificity of the effects of stimulant medication on classroom learning-related measures of cognitive processing for attention deficit disorder children.
    Balthazor MJ; Wagner RK; Pelham WE
    J Abnorm Child Psychol; 1991 Feb; 19(1):35-52. PubMed ID: 2030246
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopamine-antagonistic, anticholinergic, and GABAergic effects on declarative and procedural memory functions.
    Rammsayer TH; Rodewald S; Groh D
    Brain Res Cogn Brain Res; 2000 Jan; 9(1):61-71. PubMed ID: 10666558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Scopolamine impairs recall of one-trial stimulus-reward association in monkeys.
    Aigner TG; Mishkin M
    Behav Brain Res; 1993 Apr; 54(2):133-6. PubMed ID: 8323711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Presidential address, 1982. The pharmacology of human information processing.
    Callaway E
    Psychophysiology; 1983 Jul; 20(4):359-70. PubMed ID: 6356200
    [No Abstract]   [Full Text] [Related]  

  • 53. Cognitive effects of milacemide and methylphenidate in healthy young adults.
    Camp-Bruno JA; Herting RL
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):46-52. PubMed ID: 7862911
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of inert gas narcosis on behavior--a critical review.
    Fowler B; Ackles KN; Porlier G
    Undersea Biomed Res; 1985 Dec; 12(4):369-402. PubMed ID: 4082343
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of stimulant drugs on information processing in elderly adults.
    Halliday R; Callaway E; Naylor H; Gratzinger P; Prael R
    J Gerontol; 1986 Nov; 41(6):748-57. PubMed ID: 3772051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The central effects of scopolamine in man.
    Safer DJ; Allen RP
    Biol Psychiatry; 1971; 3(4):347-55. PubMed ID: 4950489
    [No Abstract]   [Full Text] [Related]  

  • 57. Does methylphenidate affect information processing? Findings from two studies on performance and P3b latency.
    Brumaghim JT; Klorman R; Strauss J; Lewine JD; Goldstein MG
    Psychophysiology; 1987 May; 24(3):361-73. PubMed ID: 3602294
    [No Abstract]   [Full Text] [Related]  

  • 58. Rate-decreasing effects of the atypical neuroleptic risperidone attenuated by conditions of reinforcement in a woman with mental retardation.
    Yoo JH; Williams DC; Napolitano DA; Peyton RT; Baer DM; Schroeder SR
    J Appl Behav Anal; 2003; 36(2):245-8. PubMed ID: 12858988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of methylphenidate on working memory in pigeons.
    Wright FK; White KG
    Cogn Affect Behav Neurosci; 2003 Dec; 3(4):300-8. PubMed ID: 15040550
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Scopolamine-induced deficits in acquisition of a complex spatial learning.
    Soffie M; Bronchart M; Lebailly B
    Physiol Behav; 1986; 37(1):79-84. PubMed ID: 3737726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.